Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Clinical trial NCT07671495 · COMPLETED

Trial details

NCT number: NCT07671495
Sponsor: MIPO Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage I Melanoma Stage III Melanoma Stage II Skin Melanoma

Start date: 2014-01-01
Primary completion: 2017-12-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.